BD Vialon™, a unique proprietary biomaterial, has been proven to enhance clinical and economic outcomes.
- Increases the ease of penetration
- Reduces the risks of infiltration
- Exhibits greater kink resistance
- Reduces the risks of phlebitis up to 50%
- Reduces IV restarts due to reduced complications
- Increases indwelling time
- Reduces the total IV therapy costs used due to longer indwelling times